Evidence map›Paper›PMID 39976249›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2025

Identification of a novel pyrrolo[2,3-

Qing-Qing Xun, Jing Zhang, Lei Feng, Yu-Ying Ma, Ying Li, Xiao-Long Shi

Abstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qing-Qing XunMedical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.
Jing ZhangMedical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.
Lei FengDepartment of Gastrointestinal Surgery, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.
Yu-Ying MaMedical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.
Ying LiMedical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.
Xiao-Long ShiMedical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, a novel pyrrolo[2,3-

Indexed as

Alzheimer DiseaseGlycogen Synthase Kinase 3 betaProtein Kinase InhibitorsPyridinesPyrrolesAnimalsDose-Response Relationship, DrugHumansMolecular StructureStructure-Activity RelationshipZebrafishGlycogen Synthase Kinase 3 betaProtein Kinase InhibitorsPyridinesPyrrolespyrrolo(2, 3-b)pyridineAlzheimer’s diseaseGSK-3β inhibitorneurite outgrowthpyrrolo[2,3-b]pyridinetau hyperphosphorylation

Identifiers

PMID39976249
PMCPMC11843656

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.